Zhaneta Ilieva

Recent publications · Crossref

5 total works indexed

1. Durvalumab plus platinum–etoposide versus platinum–etoposide in first-line treatment of extensive-stage small-cell lung cancer (CASPIAN): a randomised, controlled, open-label, phase 3 trial

   · 2019 · cited 1,876x

2. Non–cell autonomous toxicity in neurodegenerative disorders: ALS and beyond

   · 2009 · cited 894x

3. Preventing Microalbuminuria in Type 2 Diabetes

   · 2004 · cited 777x

4. Science Requirements and Detector Concepts for the Electron-Ion Collider

   · 2022 · cited 772x

5. Durvalumab, with or without tremelimumab, plus platinum–etoposide versus platinum–etoposide alone in first-line treatment of extensive-stage small-cell lung cancer (CASPIAN): updated results from a randomised, controlled, open-label, phase 3 trial

   · 2021 · cited 586x

via Crossref · CC0